Determinants of frailty: The added value of assessing medication

Frontiers in Aging Neuroscience

Volumn 7, Issue APR, 2015, Pages

  Coelho, Tiago ^a,b   Paúl, Constança ^b   Gobbens, Robbert J J ^c,d   Fernandes, Lia ^e  

^a POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c INHOLLAND UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

^d Zonnehuisgroep Amstelland (KBO)   (Netherlands)

^e University of Porto   (Portugal)

Author keywords

Comorbidity; Determinants; Elderly; Frailty; Medication

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ARTICLE; BARTHEL INDEX; CARDIOVASCULAR RISK; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDY; FEMALE; GERIATRIC DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; VERY ELDERLY; WEAKNESS;

EID: 84928793345     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2015.00056     Document Type: Article

References (49)

1. Abellan van Kan, G., Rolland, Y., Bergman, H., Morley, J. E., Kritchevsky, S. B., and Vellas, B. (2008). The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J. Nutr. Health Aging 12, 29-37. doi: 10.1007/BF02982161
2. Afilalo, J., Karunananthan, S., Eisenberg, M. J., Alexander, K. P., and Bergman, H. (2009). Role of frailty in patients with cardiovascular disease. Am. J. Cardiol. 103, 1616-1621. doi: 10.1016/j.amjcard.2009.01.375
3. Antoine, P., Nandrino, J. L., and Billiet, C. (2013). Awareness of deficits in Alzheimer's disease patients: analysis of performance prediction discrepancies. Psychiatry Clin. Neurosci. 67, 237-244. doi: 10.1111/pcn.12050
4. Avila-Funes, J. A., Helmer, C., Amieva, H., Barberger-Gateau, P., Le Goff, M., Ritchie, K., et al. (2008). Frailty among community-dwelling elderly people in France: the three-city study. J. Gerontol. A Biol. Sci. Med. Sci. 63, 1089-1096. doi: 10.1093/gerona/63.10.1089
5. Barreto Pde, S., Greig, C., and Ferrandez, A. M. (2012). Detecting and categorizing frailty status in older adults using a self-report screening instrument. Arch. Gerontol. Geriatr. 54, e249-e254. doi: 10.1016/j.archger.2011.08.003
6. Bergman, H., Ferrucci, L., Guralnik, J., Hogan, D. B., Hummel, S., Karunananthan, S., et al. (2007). Frailty: an emerging research and clinical paradigm-issues and controversies. J. Gerontol. A Biol. Sci. Med. Sci. 62, 731-737. doi: 10.1093/gerona/62.7.731
7. Burgess, C., Ingham, T., Woodbridge, M., Weatherall, M., and Nowitz, M. (2007). The use of antithrombotics in patients presenting with stroke and atrial fibrillation. Ther. Clin. Risk Manag. 3, 491-498.
8. Coelho, T., Santos, R., Paúl, C., Gobbens, R. J. J., and Fernandes, L. (2014). Portuguese version of the Tilburg Frailty Indicator: transcultural adaptation and psychometric validation. Geriatr. Gerontol. Int. doi: 10.1111/ggi.12373 [Epub ahead of print]
9. Collard, R. M., Boter, H., Schoevers, R. A., and Oude Voshaar, R. C. (2012). Prevalence of frailty in community-dwelling older persons: a systematic review. J. Am. Geriatr. Soc. 60, 1487-1492. doi: 10.1111/j.1532-5415.2012.04054.x
10. Farias, S. T., Mungas, D., and Jagust, W. (2005). Degree of discrepancy between self and other-reported everyday functioning by cognitive status: dementia, mild cognitive impairment, and healthy elders. Int. J. Geriatr. Psychiatry 20, 827-834. doi: 10.1002/gps.1367
11. Folstein, M. F., Folstein, S. E., and McHugh, P. R. (1975). "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198. doi: 10.1016/0022-3956(75)90026-6
12. Frank, L., Lenderking, W., Howard, K., and Cantillon, M. (2011). Patient self-report for evaluating mild cognitive impairment and prodromal Alzheimer's disease. Alzheimers Res. Ther. 3, 35. doi: 10.1186/alzrt97
13. Fried, L. P., Ferrucci, L., Darer, J., Williamson, J. D., and Anderson, G. (2004). Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J. Gerontol. A Biol. Sci. Med. Sci. 59, 255-263. doi: 10.1093/gerona/59.3.M255
14. Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., et al. (2001). Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci. 56, M146-M156. doi: 10.1093/gerona/56.3.M146
15. Fried, L. P., Walston, J., and Ferrucci, L. (2009). "Frailty," in Hazzard's Geriatric Medicine and Gerontology, eds J. B. Halter, J. G. Ouslander, M. E. Tinetti, S. Studenski, K. P. High, and S. Asthana (New York, NY: McGraw-Hill), 631-646.
16. Garcia-Garcia, F. J., Gutierrez Avila, G., Alfaro-Acha, A., Amor Andres, M. S., De Los Angeles De La Torre Lanza, M., Escribano Aparicio, M. V., et al. (2011). The prevalence of frailty syndrome in an older population from Spain. The Toledo Study for Healthy Aging. J. Nutr. Health Aging 15, 852-856. doi: 10.1007/s12603-011-0075-8
17. Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Cumming, R. G., Handelsman, D. J., et al. (2012a). High-risk prescribing and incidence of frailty among older community-dwelling men. Clin. Pharmacol. Ther. 91, 521-528. doi: 10.1038/clpt.2011.258
18. Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Waite, L., Seibel, M. J., et al. (2012b). Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J. Clin. Epidemiol. 65, 989-995. doi: 10.1016/j.jclinepi.2012.02.018
19. Gobbens, R. J., Luijkx, K. G., Wijnen-Sponselee, M. T., and Schols, J. M. (2010a). In search of an integral conceptual definition of frailty: opinions of experts. J. Am. Med. Dir. Assoc. 11, 338-343. doi: 10.1016/j.jamda.2009.09.015
20. Gobbens, R. J., Luijkx, K. G., Wijnen-Sponselee, M. T., and Schols, J. M. (2010b). Toward a conceptual definition of frail community dwelling older people. Nurs. Outlook 58, 76-86. doi: 10.1016/j.outlook.2009.09.005
21. Gobbens, R. J., Luijkx, K. G., Wijnen-Sponselee, M. T., and Schols, J. M. (2010c). Towards an integral conceptual model of frailty. J. Nutr. Health Aging 14, 175-181. doi: 10.1007/s12603-010-0045-6
22. Gobbens, R. J., van Assen, M. A., Luijkx, K. G., Wijnen-Sponselee, M. T., and Schols, J. M. (2010d). Determinants of frailty. J. Am. Med. Dir. Assoc. 11, 356-364. doi: 10.1016/j.jamda.2009.11.008
23. Gobbens, R. J., van Assen, M. A., Luijkx, K. G., Wijnen-Sponselee, M. T., and Schols, J. M. (2010e). The Tilburg Frailty Indicator: psychometric properties. J. Am. Med. Dir. Assoc. 11, 344-355. doi: 10.1016/j.jamda.2009.11.003
24. Gobbens, R. J., van Assen, M. A., Luijkx, K. G., and Schols, J. M. (2012). Testing an integral conceptual model of frailty. J. Adv. Nurs. 68, 2047-2060. doi: 10.1111/j.1365-2648.2011.05896.x
25. Hogan, D. B., MacKnight, C., and Bergman, H. (2003). Models, definitions, and criteria of frailty. Aging Clin. Exp. Res. 15(Suppl. 3), 1-29.
26. Hutcheon, S. D., Gillespie, N. D., Crombie, I. K., Struthers, A. D., and McMurdo, M. E. (2002). Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial. Heart 88, 373-377. doi: 10.1136/heart.88.4.373
27. INE. (2012). Censos 2011 Resultados Definitivos - Portugal [2011 Census Final Results - Portugal]. Lisboa: Instituto Nacional de Estatística (INE), I. P.
28. Kriegsman, D. M., Penninx, B. W., van Eijk, J. T., Boeke, A. J., and Deeg, D. J. (1996). Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J. Clin. Epidemiol. 49, 1407-1417. doi: 10.1016/S0895-4356(96)00274-0
29. Lawton, M. P., and Brody, E. M. (1969). Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9, 179-186. doi: 10.1093/geront/9.3_Part_1.179
30. Lin, E., Padmanabhan, R., and Moonis, M. (2010). Antiplatelet agents and proton pump inhibitors - personalizing treatment. Pharmgenomics Pers. Med. 3, 101-109.
31. Mahoney, F. I., and Barthel, D. W. (1965). Functional evaluation: the barthel index. Md. State Med. J. 14, 61-65.
32. Markle-Reid, M., and Browne, G. (2003). Conceptualizations of frailty in relation to older adults. J. Adv. Nurs. 44, 58-68. doi: 10.1046/j.1365-2648.2003.02767.x
33. Morley, J. E., Vellas, B., van Kan, G. A., Anker, S. D., Bauer, J. M., Bernabei, R., et al. (2013). Frailty consensus: a call to action. J. Am. Med. Dir. Assoc. 14, 392-397. doi: 10.1016/j.jamda.2013.03.022
34. NICE. (2011). Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer's Disease. NICE technology appraisal guidance 217. Available at: http://www.nice.org.uk/guidance/ta217
35. Onder, G., Penninx, B. W. J. H., Balkrishnan, R., Fried, L. P., Chaves, P. H. M., Williamson, J., et al. (2002). Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet 359, 926-930. doi: 10.1016/s0140-6736(02)08024-8
36. Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Z., Verschuren, W. M., et al. (2012). European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Int. J. Behav. Med. 19, 403-488. doi: 10.1007/s12529-012-9242-5
37. Puts, M. T., Lips, P., and Deeg, D. J. (2005). Sex differences in the risk of frailty for mortality independent of disability and chronic diseases. J. Am. Geriatr. Soc. 53, 40-47. doi: 10.1111/j.1532-5415.2005.53008.x
38. Renda, G., and de Caterina, R. (2012). Impact of antiplatelet therapy in heart disease. Adv. Cardiol. 47, 5-19. doi: 10.1159/000338060
39. Rockwood, K., and Mitnitski, A. (2007). Frailty in relation to the accumulation of deficits. J. Gerontol. A Biol. Sci. Med. Sci. 62, 722-727. doi: 10.1093/gerona/62.7.722
40. Solfrizzi, V., Scafato, E., Frisardi, V., Seripa, D., Logroscino, G., Maggi, S., et al. (2013). Frailty syndrome and the risk of vascular dementia: the italian Longitudinal Study on Aging. Alzheimers Dement. 9, 113-122. doi: 10.1016/j.jalz.2011.09.223
41. Song, X., Mitnitski, A., and Rockwood, K. (2010). Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J. Am. Geriatr. Soc. 58, 681-687. doi: 10.1111/j.1532-5415.2010.02764.x
42. Sternberg, S. A., Wershof Schwartz, A., Karunananthan, S., Bergman, H., and Mark Clarfield, A. (2011). The identification of frailty: a systematic literature review. J. Am. Geriatr. Soc. 59, 2129-2138. doi: 10.1111/j.1532-5415.2011.03597.x
43. Strandberg, T. E., and Pitkala, K. H. (2007). Frailty in elderly people. Lancet 369, 1328-1329. doi: 10.1016/S0140-6736(07)60613-8
44. Stroebe, M., Schut, H., and Stroebe, W. (2007). Health outcomes of bereavement. Lancet 370, 1960-1973. doi: 10.1016/S0140-6736(07)61816-9
45. Sumukadas, D., Witham, M. D., Struthers, A. D., and McMurdo, M. E. (2007). Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial. CMAJ 177, 867-874. doi: 10.1503/cmaj.061339
46. WHO. (1999). A Life Course Perspective of Maintaining Independence in Older Age. Geneva: World Health Organization.
47. WHO. (2014). Guidelines for ATC Classification and DDD Assignment 2015, 18th Edn. Oslo: World Health Organization Collaborating Centre for Drug Statistics Methodology.
48. Woo, J., Goggins, W., Sham, A., and Ho, S. C. (2005). Social determinants of frailty. Gerontology 51, 402-408. doi: 10.1159/000088705
49. Woods, N. F., LaCroix, A. Z., Gray, S. L., Aragaki, A., Cochrane, B. B., Brunner, R. L., et al. (2005). Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J. Am. Geriatr. Soc. 53, 1321-1330. doi: 10.1111/j.1532-5415.2005.53405.x